Fine Organic's Q2FY24 Financial Performance Review

In this financial performance review, we delve into the results of Fine Organics for the second quarter of fiscal year 2024 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23YoY (% change)Q1FY24QoQ (% change)Q2FY24
Total Income (₹crs.)938.51-40.58516.627.94557.64
Expenses (₹crs.)678.04-37.38418.321.49424.56
Net Profit (₹crs.)202.62-48.9999.763.61103.36
Margin (%)21.59-3.0519.31-0.7718.54

 

REVENUE: 
Fine Organics reported a total revenue of ₹557.64 crores for Q2FY24. This represents a significant increase of 7.94% sequentially. However, year-on-year, the company experienced a substantial decline of -40.58%.

 

EXPENSES: 
The company recorded expenses amounting to ₹424.56 crores in Q2FY24, reflecting a minor 1.49% seqeuntially. Year-on-year, expenses have decreased by -37.38% compared to ₹678.04 crores.

 

NET PROFIT: 
In the second quarter of fiscal year 2024, Fine Organics reported a net profit of ₹103.36 crores, demonstrating a modest 3.61% to Q1FY24. Nevertheless, the net profit has seen a considerable decline of -48.99% compared to the net profit in Q2FY23.

 

MARGINS: 
The margin for Q2FY24 is 18.54%, reflecting a marginal decrease of -0.77% compared to  Q1FY24. Year-on-year, the margin has declined by -3.05% from 21.59% in Q2FY23.

 

In conclusion, Fine Organics' financial performance in the second quarter of fiscal year 2024 shows a mixed picture. While the company managed to increase its revenue compared to the previous quarter, the year-on-year revenue decline remains significant. 

 

The marginal increase in net profit is promising but may require further growth to offset the substantial YoY decline. Expense management has improved compared to the previous year. 

 

Stay tuned for more updates on upcoming financial performances.

Top stories
Company

Delta Corp Q1 PAT Declines 68% YoY to Rs 22 crore in FY25

4 mins read . 13 Jul 2024 . 09:30 AM

Company

Zydus Life Gets USFDA Nod for Heart Failure Drug

3 mins read . 13 Jul 2024 . 09:23 AM

Company

RVNL Spurts 10% on Bagging Multiple Orders Worth Rs 390 Cr

4 mins read . 13 Jul 2024 . 09:18 AM

Related Blogs
blog-logo

Share Market

blog-logo

12 mins read . 12 Jul 2024

Ritesh Agarwal: The OYO Founder’s Success Story

  • 0 people read
blog-logo

Share Market

blog-logo

15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions